C R A I G A . S M I T H , P h . D . (left) Chief Scientific Officer VLST Corp. C A R L W E I S S M A N (center) President & CEO Accelerator Corp. S T E V E N R . W I L E Y, P h . D . (right) Chief Technology Officer VLST Corp. The scientific team of Drs. Craig Smith  and Steven Wiley, invented the arthritis drug Enbrel$^{®}$, which is now a multibillion dollar biotechnology product, and are  co-founders of an emerging biotechnology company dedicated to the development  of next-generation monoclonal antibody therapeutics. This company was founded,  in part, by Accelerator Corp., led by President and CEO Carl Weissman. Accelerator Corp., an innovative and  creative vehicle designed to foster  promising start-ups, is anchored by The Institute for Systems Biology, together with Alexandria and several prominent venture capital firms.